As of 2023, Reshma Kewalramani's net worth, as reported by Wallmine, is estimated to be $65.6 million.
Reshma Kewalramani is a renowned physician-scientist and accomplished pharmaceutical executive, presently holding the position of CEO at Vertex Pharmaceuticals. Over the course of her career, she has made remarkable strides in the medical field, excelling both as a clinician and as a prominent leader within the pharmaceutical industry.
Early Life
Reshma Kewalramani's life story commenced in Bombay, India, her birthplace and childhood home. However, the trajectory of her life took a significant turn when she and her family made the decision to relocate to the United States when she was just 11 years old. This momentous move marked the beginning of an inspiring journey that would witness her shatter barriers and set new standards in the biotechnology field.
Personal Life
Residing in Massachusetts, Reshma Kewalramani takes pride in being a devoted mother to twin sons, skillfully balancing her personal and professional responsibilities with admirable grace. Her life beyond the workplace, much like her professional voyage, stands as a testament to her unwavering resilience, determination, and boundless energy.
Professional Life
Reshma Kewalramani's professional journey is an impressive fusion of medicine and business, showcasing her diverse skill set. After graduating from Boston University's liberal arts/medical education program in 1998 with honors, being a Phi Beta Kappa and Summa Cum Laude, she completed her internship and residency at Massachusetts General Hospital. She further refined her medical expertise through a nephrology fellowship at the combined program of Massachusetts General Hospital and Brigham and Women's Hospital.
Following her clinical nephrology fellowship, she delved into transplantation research, and in 2015, she successfully completed the General Management Program at Harvard Business School. This distinctive combination of medical and business education laid the groundwork for her illustrious career in the biopharma sector.
Reshma Kewalramani embarked on her professional journey as a physician at Massachusetts General Hospital and Brigham and Women's Hospital. After gaining experience at Massachusetts Eye and Ear Infirmary and Massachusetts Institute of Technology, she seamlessly transitioned into the biopharma industry. Here, she held key leadership positions at Amgen for over a decade.
In 2017, she joined Vertex Pharmaceuticals, and three years later, she assumed the role of President and CEO, making history as the first female CEO of a major US biotech company. Her visionary leadership has led to groundbreaking drug developments, including the cystic fibrosis therapy drug Trikafta and the experimental apolipoprotein L1 inhibitor, VX-147. Under her guidance, Vertex has also established collaborations with CRISPR Therapeutics to advance gene-editing therapies for sickle cell disease and beta-thalassemia.
Awards and Recognitions
Reshma Kewalramani's exceptional contributions to the medical and biopharma fields have garnered well-deserved recognition over the years. She has been honored with several prestigious awards. Some of her notable achievements include receiving the American College of Physicians Associates Council Award, the American Medical Women's Association Janet M. Glasgow Memorial Achievement Citation, and the Harvard Medical School Excellence in Teaching Award.
In 2019, Kewalramani was honored with the TiE Boston Healthcare Leadership Award and was recognized as one of Boston Business Journal's Power 50. Her accomplishments also led her to be included in the inaugural Business Leaders List by Indiaspora, Business Insider's list of 10 people transforming healthcare, and the PharmaVOICE 100 list of leaders in the life sciences in 2020. In 2021, she received the International Institute of New England's Golden Door Award and was named a New Englander of the Year by the New England Council. Under her exemplary leadership, Vertex Pharmaceuticals secured the #2 spot on The Commonwealth Institute's Top Women-Led Businesses in Massachusetts in 2021.
.jpg)